Indivior Pharmaceuticals (INDV) Other Non Operating Income (2026)
Indivior Pharmaceuticals (INDV) posted Other Non Operating Income of -$18.0 million for Q1 2026.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Other Non Operating Income (2026) Analysis & Trends
Indivior Pharmaceuticals has reported Other Non Operating Income for 1 years, with the latest figure at -$18.0 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Indivior Pharmaceuticals | 4.06 Bn | 3.84 Bn | 294.00 Mn |